Tengion, Inc.

Inregen

Prokidney

Regenmedtx, LLC

Regenmed (cayman) Ltd.

Colgate Palmolive Company

International Flavors & Fragrances Inc.

Regenmed, Inc.

Richard Payne

Guy J Broze

Robert P Belko

James G Masters

Michael G Monteleone

Jeffrey Eldon Fish

Deepak Jain

John W Ludlow

Manuel J Jayo

Oluwatoyin A Knight

Namrata D Sangha

Timothy A Bertram

Joydeep Basu

Roger M Ilagan

Andrew T Bruce

Kelly Guthrie

Darell McCoy

Christopher W Genheimer

Craig R Halberstadt

Sharon C Presnell

Russell W Kelley

Alain Jacques

Georges Yianakopoulos

Benjamin Amorelli

Feng Geng

Eric S Werdin

Shay M Wallace

Benjamin Watts

Neil F Robins

Bryan R Cox

Sarah F Quinlan

Louis Oldenhove

Lori H Szeles

Alexandrine Tuzi

Xiaoyan Liu

Sumana Choudhury

Elias A Rivera

Thomas Spencer

H Scott Rapoport

David Rodriguez

Neil F Robbins

Monica A Serban

Kelly I Guthrie

Russell W Keller

Darrell Mccoy

Jr Anthony T Levorse

Iyare Amegor

Sangha Namtata

I Guthrie; Kelly

Neil Robbins

Malcolm Williams

Jacob E Shokes

Teresa B Burnette

Dominic M Justewicz

Wendy Sharp

Darell Mccoy

Sarah A Boyd

The present invention concerns bioactive renal cell populations, renal cell constructs, and methods of making and using the same.

Bioactive renal cells

The present invention concerns bioactive renal cells populations, renal cell constructs, and methods of making and using the same.

The present invention concerns phase changing injectable formulations for organ augmentation containing active agents, such as bioactive cell populations, and methods of making and using the same.

Injectable formulations for organ augmentation

The present invention relates to the regeneration, reconstruction, repair, augmentation or replacement of organs or tissue structures using scaffolds and autologous cells that are not derived from such organs or tissues.

Cell scaffold constructs

Biocompatible synthetic or natural scaffolds are provided for the reconstruction, repair, augmentation or replacement of organs or tissue structures in a patient in need of such treatment. The scaffolds are shaped to conform to at least a part of the organ or tissue structure and may be seeded with one or more cell populations. Inserts, receptacles and ports are also provided for the attachment of tubular vessels to the neo-organ scaffolds. The seeded scaffolds are implanted into the patient at the site in need of treatment to form an organized organ or tissue structure. The scaffolds may be used to form organs or tissues, such as bladders, urethras, valves, and blood vessels.

Scaffolds for organ reconstruction and augmentation

Cell-scaffold constructs

Growing community of inventors

Winston-Salem, NC, United States of America

Richard Payne